Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04804774 · ClinicalTrials.gov registry record · NA
Virtual Weight Control Program Tailored for Adults With Type 2 Diabetes (VITAL)
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT04804774 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 136 participants.
The verdict
NCT04804774, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effect of the WW program on people with Type 2 diabetes and the effect on glycemic control. This study will be a 6 month prospective, single arm clinical trial coordinated by Pennington Biomedical Research Center. Up to 150 participants will be recruited across 3 sites. Participants will have Type 2 diabetes and overweight/obesity.
Interventions
- BEHAVIORAL WW program modified for people with Type 2 diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2021-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04804774
The ClinicalTrials.gov registry entry for NCT04804774 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WW program modified for people with Type 2 diabetes is the first listed.
NCT04804774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04804774 about?
NCT04804774 is a clinical study titled "Virtual Weight Control Program Tailored for Adults With Type 2 Diabetes (VITAL)". The purpose of the study is to evaluate the effect of the WW program on people with Type 2 diabetes and the effect on glycemic control. This study will be a 6 month prospective, single arm clinical trial coordinated by Pennington Biomedical Research Center. Up to 150 participants will be recruited a...
What is the current status of trial NCT04804774?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2021-03-23. Estimated completion is 2021-12-22.
What interventions are being tested in trial NCT04804774?
The interventions under investigation include: WW program modified for people with Type 2 diabetes (BEHAVIORAL).
Who is sponsoring clinical trial NCT04804774?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.